Vaylen vs bmiMD: Pricing, formats, and refund differences
Quick verdict: Vaylen vs bmiMD favors Vaylen for lowest advertised prepaid monthly rates and multiple molecule formats, while bmiMD focuses on tirzepatide with flexible billing options and free subscription shipping. This comparison highlights pricing structure, medication formats, shipping and refund policies, clinician review timing, and regulatory disclosure.
See Vaylen plans from $83.25/mo
Overview of both providers
Vaylen is a cash-pay telehealth program selling compounded GLP-1 medications in three formats and two molecules, with headline rates shown as annualized prices on 12-month plans. bmiMD is presented as an online clinician-reviewed program focused on compounded tirzepatide with multiple billing options and free shipping on subscription orders. Both providers state that treatment is available only when a licensed clinician determines it is medically appropriate and that compounded medications are not FDA-approved.
5 key differences: pricing structure, medication formats, billing flexibility, shipping and refunds, clinician access
1. Pricing structure and headline rates
Vaylen publishes semaglutide from $83.25/mo on a 12-month plan billed upfront, with month-to-month semaglutide shown at $224/mo. Oral semaglutide is $99/mo on the prepaid 12-month program or $249/mo month to month. Tirzepatide is listed at $149/mo on the 12-month plan or $299/mo monthly. Every 12-month headline rate is billed upfront in a single charge.
bmiMD advertises tirzepatide with four billing options: $139/mo on a 12-month plan, $149/mo on a 6-month plan, $159/mo on a 3-month plan, or $179/mo month-to-month. bmiMD emphasizes lower long-term monthly equivalents with multimonth plans.
2. Medication formats and molecule choices
Vaylen offers compounded semaglutide injections once weekly, oral semaglutide tablets taken daily, and weekly tirzepatide, allowing a clinician to switch molecules or formats on one platform. bmiMD focuses on compounded tirzepatide only, with no published offering of semaglutide formats in the captured evidence.
3. Billing commitments, refunds, and prepaid terms
Vaylen requires prepaying the full 12-month rate before clinician review but states a full refund for that billing cycle if the clinician declines to prescribe. The landing page notes no published terms for unused portions of a prepaid year if a patient cancels mid-treatment. bmiMD also advertises refundability if a patient is not eligible and calls the offer 100 percent refundable if not eligible, but the comparison evidence emphasizes confirming total prepaid charge before enrolling.
4. Shipping, turnaround, and clinician review timing
Vaylen promises free discreet shipping in 1 to 3 business days and clinician review within 24 hours after the health form is submitted. bmiMD highlights free subscription shipping on every order and reports quick turnaround with online refills and delivery; bmiMD also offers 24/7 clinician access in its captured features.
5. Regulatory and quality disclosures
Both providers state that their compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. bmiMD adds that medications are prepared in state-licensed pharmacies and independently verified in FDA- and DEA-registered labs in the captured landing-page claims. Vaylen explicitly notes its compounded medications are prepared by licensed U.S. pharmacies against an individual prescription.
| Criteria | Vaylen | bmiMD |
|---|---|---|
| Primary molecules and formats | Semaglutide injectable, oral semaglutide tablet, tirzepatide | Compounded tirzepatide |
| Starting prepaid 12-month price | Semaglutide $83.25/mo; oral $99/mo; tirzepatide $149/mo | Tirzepatide $139/mo (12-month plan) |
| Month-to-month price shown | Semaglutide $224/mo; oral $249/mo; tirzepatide $299/mo | Tirzepatide $179/mo |
| Billing flexibility | Prepay required for headline rates; full-year charge billed upfront | Four billing options: 12, 6, 3, or 1 month |
| Refund if not eligible | Full refund for that billing cycle if clinician declines to prescribe | Advertises 100% refundable if not eligible; confirm total prepaid charge |
| Shipping and turnaround | Free discreet shipping in 1 to 3 business days; clinician review within 24 hours | Free subscription shipping; online refills and delivery; reported quick turnaround |
| Clinician access | Licensed U.S. clinicians via OpenLoop Health; clinician review | 24/7 clinician access advertised |
How to choose between Vaylen and bmiMD
Vaylen vs bmiMD decision points are straightforward from the captured evidence. If your priority is the lowest advertised prepaid monthly rate for semaglutide and access to both injectable and oral formats plus tirzepatide on one platform, Vaylen presents those headline advantages. If you want a provider that focuses on tirzepatide with multiple billing terms and continuous clinician access plus free subscription shipping, bmiMD is positioned for that need.
Compare Vaylen formats and pricing
View bmiMD tirzepatide billing options
Final notes and regulatory reminder
Both companies sell compounded medications and include the regulatory disclosure that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Treatment is available only when a licensed clinician determines it is medically appropriate. The captured materials make no guarantees about medical outcomes.
Start Vaylen enrollment and clinician review
Choose one if…
Choose Vaylen if you want the lowest advertised prepaid monthly semaglutide rate, access to semaglutide injectable and oral formats and tirzepatide on one platform, and a refund if a clinician declines to prescribe. Choose bmiMD if you want a tirzepatide-focused offering with four billing options and free subscription shipping plus advertised 24/7 clinician access.